Rare diseases
Investigational molecules
Locations
Study on the Effectiveness and Safety of Vedolizumab for Children with Chronic Pouchitis Using a Drug Combination
BelgiumStudy on Transmural Healing in Patients with Moderate to Severe Crohn's Disease Using Upadacitinib and Drug Combination
BelgiumStudy Comparing Vedolizumab and Adalimumab for Crohn's Disease Patients Who No Longer Respond to Adalimumab
FranceStudy on Preventing Crohn's Disease Recurrence After Surgery Using Risankizumab and Drug Combination in Adults at Risk
BelgiumStudy of Vedolizumab for Children with Moderate to Severe Ulcerative Colitis or Crohn's Disease
BelgiumMethoxsalen (ECP) versus drug combination for steroid‑refractory immune‑related colitis or hepatitis in metastatic melanoma on checkpoint therapy
AustriaA study comparing vedolizumab, filgotinib, ustekinumab, and infliximab to maintain remission in patients with ulcerative colitis
FranceStudy on the Safety and Effectiveness of OD-07656 and Vedolizumab for Patients with Moderate to Severe Ulcerative Colitis
AustriaStudy on Fecal Microbiota Transplantation with Infliximab and Vedolizumab for Patients with Ulcerative Colitis
FinlandStudy on the Effects of Adalimumab, Vedolizumab, and Tofacitinib on Heart Health in Patients with Ulcerative Colitis
FranceStudy Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis
BulgariaStudy on the Effectiveness and Safety of PB016 and Vedolizumab for Patients with Moderately to Severely Active Ulcerative Colitis
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
